PETER JONES to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications PETER JONES has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.570
-
Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis. J Am Heart Assoc. 2012 Dec; 1(6):e001800.
Score: 0.248
-
Update on lipids and C-reactive protein in acute and chronic coronary heart disease. Tex Heart Inst J. 2010; 37(3):307-8.
Score: 0.202
-
Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials. Am J Cardiol. 2016 Dec 15; 118(12):1805-1811.
Score: 0.080
-
Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus. Am J Cardiol. 2007 Feb 19; 99(4A):133B-140B.
Score: 0.041